Entry - #604326 - SPINOCEREBELLAR ATAXIA 12; SCA12 - OMIM
# 604326

SPINOCEREBELLAR ATAXIA 12; SCA12


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
5q32 Spinocerebellar ataxia 12 604326 AD 3 PPP2R2B 604325
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
HEAD & NECK
Face
- Facial myokymia
Eyes
- Ocular movement abnormalities
NEUROLOGIC
Central Nervous System
- Progressive cerebellar ataxia
- Upper extremity action tremor
- Head tremor
- Dysarthria
- Dysmetria
- Dysdiadochokinesis
- Hyperreflexia
- Parkinsonism
- Axial dystonia
- Dementia
- Cortical atrophy
- Cerebellar atrophy
Peripheral Nervous System
- Subclinical sensory or sensorimotor neuropathy
Behavioral Psychiatric Manifestations
- Depression
- Anxiety
- Delusions
MISCELLANEOUS
- Age at onset 8 to 55 years (mean 40 years)
- Normal CAG repeat length is 7 to 32 triplets
- Pathogenic CAG repeat length is 51 to 78 triplets
MOLECULAR BASIS
- Caused by expanded CAG trinucleotide repeats in the beta subunit of the protein phosphatase 2 gene (PPP2R2B, 604325.0001)
Spinocerebellar ataxia - PS164400 - 49 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.33 Spinocerebellar ataxia 21 AD 3 607454 TMEM240 616101
1p35.2 Spinocerebellar ataxia 47 AD 3 617931 PUM1 607204
1p32.2-p32.1 Spinocerebellar ataxia 37 AD 3 615945 DAB1 603448
1p13.2 Spinocerebellar ataxia 19 AD 3 607346 KCND3 605411
2p16.1 Spinocerebellar ataxia 25 AD 3 608703 PNPT1 610316
3p26.1 Spinocerebellar ataxia 15 AD 3 606658 ITPR1 147265
3p26.1 Spinocerebellar ataxia 29, congenital nonprogressive AD 3 117360 ITPR1 147265
3p14.1 Spinocerebellar ataxia 7 AD 3 164500 ATXN7 607640
3q25.2 ?Spinocerebellar ataxia 43 AD 3 617018 MME 120520
4q27 ?Spinocerebellar ataxia 41 AD 3 616410 TRPC3 602345
4q34.3-q35.1 ?Spinocerebellar ataxia 30 AD 2 613371 SCA30 613371
5q32 Spinocerebellar ataxia 12 AD 3 604326 PPP2R2B 604325
5q33.1 Spinocerebellar ataxia 45 AD 3 617769 FAT2 604269
6p22.3 Spinocerebellar ataxia 1 AD 3 164400 ATXN1 601556
6p12.1 Spinocerebellar ataxia 38 AD 3 615957 ELOVL5 611805
6q14.1 Spinocerebellar ataxia 34 AD 3 133190 ELOVL4 605512
6q24.3 Spinocerebellar ataxia 44 AD 3 617691 GRM1 604473
6q27 Spinocerebellar ataxia 17 AD 3 607136 TBP 600075
7q21.2 ?Spinocerebellar ataxia 49 AD 3 619806 SAMD9L 611170
7q22-q32 Spinocerebellar ataxia 18 AD 2 607458 SCA18 607458
7q32-q33 Spinocerebellar ataxia 32 AD 2 613909 SCA32 613909
11q12 Spinocerebellar ataxia 20 AD 4 608687 SCA20 608687
11q13.2 Spinocerebellar ataxia 5 AD 3 600224 SPTBN2 604985
12q24.12 Spinocerebellar ataxia 2 AD 3 183090 ATXN2 601517
12q24.12 {Amyotrophic lateral sclerosis, susceptibility to, 13} AD 3 183090 ATXN2 601517
13q21 Spinocerebellar ataxia 8 AD 3 608768 ATXN8 613289
13q21.33 Spinocerebellar ataxia 8 AD 3 608768 ATXN8OS 603680
13q33.1 Spinocerebellar ataxia 27B, late-onset AD 3 620174 FGF14 601515
13q33.1 Spinocerebellar ataxia 27A AD 3 193003 FGF14 601515
14q32.11-q32.12 ?Spinocerebellar ataxia 40 AD 3 616053 CCDC88C 611204
14q32.12 Machado-Joseph disease AD 3 109150 ATXN3 607047
15q15.2 Spinocerebellar ataxia 11 AD 3 604432 TTBK2 611695
16p13.3 Spinocerebellar ataxia 48 AD 3 618093 STUB1 607207
16q21 Spinocerebellar ataxia 31 AD 3 117210 BEAN1 612051
16q22.1 Spinocerebellar ataxia 51 AD 3 620947 THAP11 609119
16q22.2-q22.3 Spinocerebellar ataxia 4 AD 3 600223 ZFHX3 104155
17q21.33 Spinocerebellar ataxia 42 AD 3 616795 CACNA1G 604065
17q25.3 Spinocerebellar ataxia 50 AD 3 620158 NPTX1 602367
18p11.21 Spinocerebellar ataxia 28 AD 3 610246 AFG3L2 604581
19p13.3 ?Spinocerebellar ataxia 26 AD 3 609306 EEF2 130610
19p13.13 Spinocerebellar ataxia 6 AD 3 183086 CACNA1A 601011
19q13.2 ?Spinocerebellar ataxia 46 AD 3 617770 PLD3 615698
19q13.33 Spinocerebellar ataxia 13 AD 3 605259 KCNC3 176264
19q13.42 Spinocerebellar ataxia 14 AD 3 605361 PRKCG 176980
20p13 Spinocerebellar ataxia 23 AD 3 610245 PDYN 131340
20p13 Spinocerebellar ataxia 35 AD 3 613908 TGM6 613900
20p13 Spinocerebellar ataxia 36 AD 3 614153 NOP56 614154
22q13.31 Spinocerebellar ataxia 10 AD 3 603516 ATXN10 611150
Not Mapped Spinocerebellar ataxia 9 612876 SCA9 612876

TEXT

A number sign (#) is used with this entry because spinocerebellar ataxia-12 (SCA12) is caused by a heterozygous expansion of a CAG repeat in a brain-specific regulatory subunit of the protein phosphatase PP2A (PPP2R2B; 604325) on chromosome 5q32.

Normal alleles carry 7 to 32 triplets, whereas disease alleles carry 51 to 78 triplets (Bahl et al., 2005).

For a general discussion of autosomal dominant spinocerebellar ataxia, see SCA1 (164400).


Clinical Features

Holmes et al. (1999) identified a novel form of autosomal dominant spinocerebellar ataxia (SCA), termed SCA12, in a large pedigree, 'R,' of German descent. The phenotype was variable, but the prototypic phenotype was that of a classic spinocerebellar ataxia, and the disease resembled the spinocerebellar ataxias more closely than any other form of neurodegenerative disorder. Age of onset ranged from 8 to 55 years. Most individuals presented in the fourth decade with upper extremity tremor, progressing over several decades to include head tremor, gait ataxia, dysmetria, dysdiadokinesis, hyperreflexia, paucity of movement, abnormal eye movements, and, in the oldest subjects, dementia. MRI or CT scans of 5 cases indicated both cortical and cerebellar atrophy. O'Hearn et al. (2001) further characterized the phenotype of the 'R' pedigree and found that action tremor of the head and arms was the most distinguishing feature in comparison to other dominant SCAs.

Bahl et al. (2005) reported 25 patients from 20 Indian families with SCA12 who were all members of an endogamous group with origins in the state of Haryana in northern India. Five of the families had been previously reported by Srivastava et al. (2001). Age at onset ranged from 26 to 56 years (mean of 40.2 years), and most presented with upper extremity tremor. Other features included hyperreflexia, dysarthria, and mild or no gait ataxia. Two individuals had axial dystonia, and 3 had facial myokymia. Almost half of patients had a subclinical sensory or sensorimotor neuropathy. Brain MRI or CT scan showed cerebellar and cerebral cortical atrophy. Anticipation was not observed.


Inheritance

The transmission pattern of SCA12 in the family reported by Holmes et al. (1999) was consistent with autosomal dominant inheritance.


Molecular Genetics

Holmes et al. (1999) used repeat expansion detection (RED), as described by Schalling et al. (1993), to identify an expanded CAG repeat in the PPP2R2B gene (604325.0001) in the proband and other affected family members with SCA12. Using PCR analysis, they demonstrated that the expression was not 1 of 8 CAG repeats associated with a neurodegenerative disease or 1 of 3 CAG repeats known to undergo nonpathogenic expansion. From the proband, they cloned a 2.5-kb genomic clone that contained a repeat of 93 uninterrupted CAGs. There was no apparent correlation between repeat size and age of onset, although the range of expanded alleles was relatively narrow (66 to 78 repeats) and the precise age of onset of tremor, typically the first symptom, was difficult to define in this disorder.

Holmes et al. (1999) assessed the PPP2R2B CAG repeat length in 394 unrelated neurologically normal individuals and 1,099 individuals with neurologic diseases; no expansion was detected, suggesting that SCA12 is rare. The CAG tract lies 133 nucleotides upstream of the reported transcription start site of the PPP2R2B gene (604325), encoding a brain-specific regulatory subunit of the protein phosphatase PP2A. The PPP2R2B gene had been mapped to 5q31-q33 between markers D5S436 and D5S470. Although the possibility that the CAG tract may lie within an unidentified gene overlapping or adjacent to PPP2R2B, an antibody probe did not detect polyglutamine expansions in protein derived from lymphoblastoid cell lines of affected family members. A lod score of 4.61 at theta = 0.0 was obtained for linkage between the expanded repeat and the disorder. It was possible that the expansion was in linkage disequilibrium with a second, as-yet-unidentified, causative mutation. However, the correlation between repeat expansion and disease in pedigree R, the lack of expansions in controls, and the known capacity of expansion mutations outside of protein-coding regions to cause disease indicated that the expansion was causative.


Population Genetics

In a study of 145 families with autosomal dominant cerebellar ataxia (ADCA), Fujigasaki et al. (2001) identified a family from India in which 6 affected and 3 unaffected members had an expanded CAG repeat in the PPP2R2B gene (604325.0001). They determined the distribution of normal PPP2R2B repeat length in 157 French and 100 Indian control subjects. In the French population normal alleles contained 9 to 18 CAG triplets, most frequently 10. In the Indian population, lengths of up to 45 CAG triplets were observed, but the most common allele also carried 10 triplets.

Among 293 individuals with ADCA from 77 Indian families, Srivastava et al. (2001) found an expanded SCA12 repeat in 6 patients and 3 asymptomatic at-risk individuals from 5 families, which accounted for 7% of the ADCA cases. The expanded allele length ranged from 55 to 69 repeat units. Notable clinical features included age of onset from 26 to 50 years, initial presentation of hand tremor, lack of dementia, and evidence of a subclinical sensory and motor neuropathy. Of the 77 families, SCA1 (164400) mutation was found in 15.6%, SCA2 (183090) in 24.7%, and SCA3 (109150) and SCA7 (164500) in 2.6% each. SCA6 (183086), SCA8 (603680), and DRPLA (607462) mutations were not found.

In an ataxia clinic in California, Cholfin et al. (2001) screened 180 kindreds for the SCA12 mutation. The patients were of highly diverse ethnic origins. None was found to carry the SCA12 expansion. The authors concluded that the SCA12 mutation is a rare cause of spinocerebellar degeneration but that it should be considered in patients with an atypical clinical phenotype, especially when tremor is initially present.

Among 20 families from northern India with SCA12, Bahl et al. (2005) identified expanded CAG repeats ranging from 51 to 69 triplets. Unaffected individuals had repeats ranging from 8 to 23 triplets. Of note, 1 asymptomatic individual was homozygous for an expanded repeat (52 and 59 triplets). Haplotype analysis identified 1 haplotype that was associated with the disease alleles, indicating a common founder. Bahl et al. (2005) estimated that SCA12 accounts for about 16% of all ADCA cases in northern India.


REFERENCES

  1. Bahl, S., Virdi, K., Mittal, U., Sachdeva, M. P., Kalla, A. K., Holmes, S. E., O'Hearn, E., Margolis, R. L., Jain, S., Srivastava, A. K., Mukerji, M. Evidence of a common founder for SCA12 in the Indian population. Ann. Hum. Genet. 69: 528-534, 2005. [PubMed: 16138911, related citations] [Full Text]

  2. Cholfin, J. A., Sobrido, M.-J., Perlman, S., Pulst, S. M., Geschwind, D. H. The SCA12 mutation as a rare cause of spinocerebellar ataxia. Arch. Neurol. 58: 1833-1835, 2001. [PubMed: 11708992, related citations] [Full Text]

  3. Fujigasaki, H., Verma, I. C., Camuzat, A., Margolis, R. L., Zander, C., Lebre, A.-S., Jamot, L., Saxena, R., Anand, I., Holmes, S. E., Ross, C. A., Durr, A., Brice, A. SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann. Neurol. 49: 117-121, 2001. [PubMed: 11198281, related citations]

  4. Holmes, S. E., O'Hearn, E. E., McInnis, M. G., Gorelick-Feldman, D. A., Kleiderlein, J. J., Callahan, C., Kwak, N. G., Ingersoll-Ashworth, R. G., Sherr, M., Sumner, A. J., Sharp, A. H., Ananth, U., Seltzer, W. K., Boss, M. A., Vieria-Saecker, A.-M., Epplen, J. T., Riess, O., Ross, C. A., Margolis, R. L. Expansion of a novel CAG trinucleotide repeat in the 5-prime region of PPP2R2B is associated with SCA12. (Letter) Nature Genet. 23: 391-392, 1999. [PubMed: 10581021, related citations] [Full Text]

  5. O'Hearn, E., Holmes, S. E., Calvert, P. C., Ross, C. A., Margolis, R. L. SCA-12: tremor with cerebellar and cortical atrophy is associated with a CAG repeat expansion. Neurology 56: 299-303, 2001. [PubMed: 11171892, related citations] [Full Text]

  6. Schalling, M., Hudson, T. J., Buetow, K. H., Housman, D. E. Direct detection of novel expanded trinucleotide repeats in the human genome. Nature Genet. 4: 135-139, 1993. [PubMed: 8348150, related citations] [Full Text]

  7. Srivastava, A. K., Choudhry, S., Gopinath, M. S., Roy, S., Tripathi, M., Brahmachari, S. K., Jain, S. Molecular and clinical correlation in five Indian families with spinocerebellar ataxia 12. Ann. Neurol. 50: 796-800, 2001. [PubMed: 11761478, related citations] [Full Text]


Cassandra L. Kniffin - updated : 3/30/2010
Cassandra L. Kniffin - updated : 10/28/2002
Victor A. McKusick - updated : 2/22/2002
Victor A. McKusick - updated : 12/21/2001
Kathryn R. Wagner - updated : 8/2/2001
Creation Date:
Victor A. McKusick : 11/30/1999
carol : 02/08/2024
carol : 08/17/2016
alopez : 09/22/2011
wwang : 8/4/2010
wwang : 4/6/2010
ckniffin : 3/30/2010
ckniffin : 3/30/2010
wwang : 4/23/2008
carol : 1/24/2003
carol : 11/13/2002
ckniffin : 10/28/2002
ckniffin : 8/7/2002
carol : 3/11/2002
cwells : 3/5/2002
terry : 2/22/2002
cwells : 1/10/2002
cwells : 1/2/2002
terry : 12/21/2001
carol : 8/2/2001
joanna : 1/19/2001
alopez : 12/7/1999
alopez : 12/1/1999
alopez : 11/30/1999

# 604326

SPINOCEREBELLAR ATAXIA 12; SCA12


SNOMEDCT: 719208005;   ORPHA: 98762;   DO: 0050962;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
5q32 Spinocerebellar ataxia 12 604326 Autosomal dominant 3 PPP2R2B 604325

TEXT

A number sign (#) is used with this entry because spinocerebellar ataxia-12 (SCA12) is caused by a heterozygous expansion of a CAG repeat in a brain-specific regulatory subunit of the protein phosphatase PP2A (PPP2R2B; 604325) on chromosome 5q32.

Normal alleles carry 7 to 32 triplets, whereas disease alleles carry 51 to 78 triplets (Bahl et al., 2005).

For a general discussion of autosomal dominant spinocerebellar ataxia, see SCA1 (164400).


Clinical Features

Holmes et al. (1999) identified a novel form of autosomal dominant spinocerebellar ataxia (SCA), termed SCA12, in a large pedigree, 'R,' of German descent. The phenotype was variable, but the prototypic phenotype was that of a classic spinocerebellar ataxia, and the disease resembled the spinocerebellar ataxias more closely than any other form of neurodegenerative disorder. Age of onset ranged from 8 to 55 years. Most individuals presented in the fourth decade with upper extremity tremor, progressing over several decades to include head tremor, gait ataxia, dysmetria, dysdiadokinesis, hyperreflexia, paucity of movement, abnormal eye movements, and, in the oldest subjects, dementia. MRI or CT scans of 5 cases indicated both cortical and cerebellar atrophy. O'Hearn et al. (2001) further characterized the phenotype of the 'R' pedigree and found that action tremor of the head and arms was the most distinguishing feature in comparison to other dominant SCAs.

Bahl et al. (2005) reported 25 patients from 20 Indian families with SCA12 who were all members of an endogamous group with origins in the state of Haryana in northern India. Five of the families had been previously reported by Srivastava et al. (2001). Age at onset ranged from 26 to 56 years (mean of 40.2 years), and most presented with upper extremity tremor. Other features included hyperreflexia, dysarthria, and mild or no gait ataxia. Two individuals had axial dystonia, and 3 had facial myokymia. Almost half of patients had a subclinical sensory or sensorimotor neuropathy. Brain MRI or CT scan showed cerebellar and cerebral cortical atrophy. Anticipation was not observed.


Inheritance

The transmission pattern of SCA12 in the family reported by Holmes et al. (1999) was consistent with autosomal dominant inheritance.


Molecular Genetics

Holmes et al. (1999) used repeat expansion detection (RED), as described by Schalling et al. (1993), to identify an expanded CAG repeat in the PPP2R2B gene (604325.0001) in the proband and other affected family members with SCA12. Using PCR analysis, they demonstrated that the expression was not 1 of 8 CAG repeats associated with a neurodegenerative disease or 1 of 3 CAG repeats known to undergo nonpathogenic expansion. From the proband, they cloned a 2.5-kb genomic clone that contained a repeat of 93 uninterrupted CAGs. There was no apparent correlation between repeat size and age of onset, although the range of expanded alleles was relatively narrow (66 to 78 repeats) and the precise age of onset of tremor, typically the first symptom, was difficult to define in this disorder.

Holmes et al. (1999) assessed the PPP2R2B CAG repeat length in 394 unrelated neurologically normal individuals and 1,099 individuals with neurologic diseases; no expansion was detected, suggesting that SCA12 is rare. The CAG tract lies 133 nucleotides upstream of the reported transcription start site of the PPP2R2B gene (604325), encoding a brain-specific regulatory subunit of the protein phosphatase PP2A. The PPP2R2B gene had been mapped to 5q31-q33 between markers D5S436 and D5S470. Although the possibility that the CAG tract may lie within an unidentified gene overlapping or adjacent to PPP2R2B, an antibody probe did not detect polyglutamine expansions in protein derived from lymphoblastoid cell lines of affected family members. A lod score of 4.61 at theta = 0.0 was obtained for linkage between the expanded repeat and the disorder. It was possible that the expansion was in linkage disequilibrium with a second, as-yet-unidentified, causative mutation. However, the correlation between repeat expansion and disease in pedigree R, the lack of expansions in controls, and the known capacity of expansion mutations outside of protein-coding regions to cause disease indicated that the expansion was causative.


Population Genetics

In a study of 145 families with autosomal dominant cerebellar ataxia (ADCA), Fujigasaki et al. (2001) identified a family from India in which 6 affected and 3 unaffected members had an expanded CAG repeat in the PPP2R2B gene (604325.0001). They determined the distribution of normal PPP2R2B repeat length in 157 French and 100 Indian control subjects. In the French population normal alleles contained 9 to 18 CAG triplets, most frequently 10. In the Indian population, lengths of up to 45 CAG triplets were observed, but the most common allele also carried 10 triplets.

Among 293 individuals with ADCA from 77 Indian families, Srivastava et al. (2001) found an expanded SCA12 repeat in 6 patients and 3 asymptomatic at-risk individuals from 5 families, which accounted for 7% of the ADCA cases. The expanded allele length ranged from 55 to 69 repeat units. Notable clinical features included age of onset from 26 to 50 years, initial presentation of hand tremor, lack of dementia, and evidence of a subclinical sensory and motor neuropathy. Of the 77 families, SCA1 (164400) mutation was found in 15.6%, SCA2 (183090) in 24.7%, and SCA3 (109150) and SCA7 (164500) in 2.6% each. SCA6 (183086), SCA8 (603680), and DRPLA (607462) mutations were not found.

In an ataxia clinic in California, Cholfin et al. (2001) screened 180 kindreds for the SCA12 mutation. The patients were of highly diverse ethnic origins. None was found to carry the SCA12 expansion. The authors concluded that the SCA12 mutation is a rare cause of spinocerebellar degeneration but that it should be considered in patients with an atypical clinical phenotype, especially when tremor is initially present.

Among 20 families from northern India with SCA12, Bahl et al. (2005) identified expanded CAG repeats ranging from 51 to 69 triplets. Unaffected individuals had repeats ranging from 8 to 23 triplets. Of note, 1 asymptomatic individual was homozygous for an expanded repeat (52 and 59 triplets). Haplotype analysis identified 1 haplotype that was associated with the disease alleles, indicating a common founder. Bahl et al. (2005) estimated that SCA12 accounts for about 16% of all ADCA cases in northern India.


REFERENCES

  1. Bahl, S., Virdi, K., Mittal, U., Sachdeva, M. P., Kalla, A. K., Holmes, S. E., O'Hearn, E., Margolis, R. L., Jain, S., Srivastava, A. K., Mukerji, M. Evidence of a common founder for SCA12 in the Indian population. Ann. Hum. Genet. 69: 528-534, 2005. [PubMed: 16138911] [Full Text: https://doi.org/10.1046/j.1529-8817.2005.00173.x]

  2. Cholfin, J. A., Sobrido, M.-J., Perlman, S., Pulst, S. M., Geschwind, D. H. The SCA12 mutation as a rare cause of spinocerebellar ataxia. Arch. Neurol. 58: 1833-1835, 2001. [PubMed: 11708992] [Full Text: https://doi.org/10.1001/archneur.58.11.1833]

  3. Fujigasaki, H., Verma, I. C., Camuzat, A., Margolis, R. L., Zander, C., Lebre, A.-S., Jamot, L., Saxena, R., Anand, I., Holmes, S. E., Ross, C. A., Durr, A., Brice, A. SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann. Neurol. 49: 117-121, 2001. [PubMed: 11198281]

  4. Holmes, S. E., O'Hearn, E. E., McInnis, M. G., Gorelick-Feldman, D. A., Kleiderlein, J. J., Callahan, C., Kwak, N. G., Ingersoll-Ashworth, R. G., Sherr, M., Sumner, A. J., Sharp, A. H., Ananth, U., Seltzer, W. K., Boss, M. A., Vieria-Saecker, A.-M., Epplen, J. T., Riess, O., Ross, C. A., Margolis, R. L. Expansion of a novel CAG trinucleotide repeat in the 5-prime region of PPP2R2B is associated with SCA12. (Letter) Nature Genet. 23: 391-392, 1999. [PubMed: 10581021] [Full Text: https://doi.org/10.1038/70493]

  5. O'Hearn, E., Holmes, S. E., Calvert, P. C., Ross, C. A., Margolis, R. L. SCA-12: tremor with cerebellar and cortical atrophy is associated with a CAG repeat expansion. Neurology 56: 299-303, 2001. [PubMed: 11171892] [Full Text: https://doi.org/10.1212/wnl.56.3.299]

  6. Schalling, M., Hudson, T. J., Buetow, K. H., Housman, D. E. Direct detection of novel expanded trinucleotide repeats in the human genome. Nature Genet. 4: 135-139, 1993. [PubMed: 8348150] [Full Text: https://doi.org/10.1038/ng0693-135]

  7. Srivastava, A. K., Choudhry, S., Gopinath, M. S., Roy, S., Tripathi, M., Brahmachari, S. K., Jain, S. Molecular and clinical correlation in five Indian families with spinocerebellar ataxia 12. Ann. Neurol. 50: 796-800, 2001. [PubMed: 11761478] [Full Text: https://doi.org/10.1002/ana.10048]


Contributors:
Cassandra L. Kniffin - updated : 3/30/2010
Cassandra L. Kniffin - updated : 10/28/2002
Victor A. McKusick - updated : 2/22/2002
Victor A. McKusick - updated : 12/21/2001
Kathryn R. Wagner - updated : 8/2/2001

Creation Date:
Victor A. McKusick : 11/30/1999

Edit History:
carol : 02/08/2024
carol : 08/17/2016
alopez : 09/22/2011
wwang : 8/4/2010
wwang : 4/6/2010
ckniffin : 3/30/2010
ckniffin : 3/30/2010
wwang : 4/23/2008
carol : 1/24/2003
carol : 11/13/2002
ckniffin : 10/28/2002
ckniffin : 8/7/2002
carol : 3/11/2002
cwells : 3/5/2002
terry : 2/22/2002
cwells : 1/10/2002
cwells : 1/2/2002
terry : 12/21/2001
carol : 8/2/2001
joanna : 1/19/2001
alopez : 12/7/1999
alopez : 12/1/1999
alopez : 11/30/1999